NCT03593707View on ClinicalTrials.gov

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

January 17, 2019

Study Completion Date

February 13, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Metformin

Metformin

DRUG

PF-06865571

PF-06865571

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY